Service de pharmacie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


352 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ...
 
Safety of Monoclonal Antibodies Inhibiting PCSK9 in Pregnancy: Disproportionality Analysis in VigiBase®.
Noseda R., Bedussi F., Panchaud A., Ceschi A. Clinical pharmacology and therapeutics. Peer-reviewed.
 
When gravimetry is debated by sponsors of clinical studies.
Voidey A., Sommer I., Marino A., Carrez L., Sadeghipour F. European journal of hospital pharmacy. Peer-reviewed.
 
Assessing the applicability and appropriateness of ChatGPT in answering clinical pharmacy questions.
Fournier A., Fallet C., Sadeghipour F., Perrottet N., 2024/05. Annales pharmaceutiques francaises, 82 (3) pp. 507-513. Peer-reviewed.
 
Post-COVID-19 condition: recommendations for pregnant individuals.
Maisonneuve E., Favre G., Boucoiran I., Dashraath P., Panchaud A., Baud D., 2024/05. The Lancet regional health. Europe, 40 p. 100916. Peer-reviewed.
 
Does the introduction of an infliximab biosimilar always result in savings for hospitals? A descriptive study using real-world data.
Krstic M., Devaud J.C., Sadeghipour F., Marti J., 2024/04/29. Health economics review, 14 (1) p. 31. Peer-reviewed.
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.
Dao K., Shechtman S., Weber-Schoendorfer C., Diav-Citrin O., Murad R.H., Berlin M., Hazan A., Richardson J.L., Eleftheriou G., Rousson V. et al., 2024/04/24. BMJ open, 14 (4) pp. e083550. Peer-reviewed.
 
Lutte contre l’antibiorésistance : audits des pratiques pour cibler les actions [Combating antimicrobial resistance: audits of practices to target actions]
Valladares P.U., Perrottet N., Senn L., Moulin E., 2024/04/10. Revue medicale suisse, 20 (869) pp. 739-742. Peer-reviewed.
Investigations of an increased incidence of non-Aspergillus invasive mould infections in an onco-haematology unit.
Stavropoulou E., Huguenin A., Caruana G., Opota O., Perrottet N., Blanc D.S., Grandbastien B., Senn L., Bochud P.Y., Lamoth F., 2024/03/26. Swiss medical weekly, 154 p. 3730. Peer-reviewed.
Development of a generic sample preparation method using dispersive liquid-liquid microextraction for the monitoring of leachable compounds in hospital pharmacy-prepared prefilled drug products.
Bello W., Pezzatti J., Rudaz S., Sadeghipour F., 2024/03/14. Analytical methods, 16 (11) pp. 1697-1707. Peer-reviewed.
 
Optimizing pharmaceutical management of clinical trials.
Farhat A., Voidey A., Sommer I., Carrez L., Sadeghipour F., 2024/03. Annales pharmaceutiques francaises, 82 (2) pp. 285-291. Peer-reviewed.
 
SSRIs in Pregnancy-What Offspring Brain Volumes Can and Cannot Tell Us.
Ceulemans M., Damkier P., Panchaud A., 2024/03/01. JAMA psychiatry, 81 (3) p. 317. Peer-reviewed.
 
Patisiran exposure in early pregnancy: a case report.
Loser V., Baumgartner T., Legardeur H., Panchaud A., Théaudin M., 2024. Therapeutic advances in neurological disorders, 17 p. 17562864241239755. Peer-reviewed.
Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project.
Nordeng H., Wegler C., Lindqvist A., Melander E., Magnusson M., Gandia P., Panchaud A., Baranczewski P., Spigset O., 2024/01. Basic & clinical pharmacology & toxicology, 134 (1) pp. 153-164. Peer-reviewed.
Development of a generic approach for monitoring leachable compounds in hospital pharmacy-prepared prefilled plastic packaging by ultrahigh-performance liquid chromatography coupled to high-resolution mass spectrometry with postcolumn infusion.
Bello W., Pezzatti J., Berger-Gryllaki M., Rudaz S., Sadeghipour F., 2023/11/30. Journal of pharmaceutical and biomedical analysis, 236 p. 115640. Peer-reviewed.
 
Lutétium-177 en Médecine Nucléaire
Couturier O.-F., Gonnet F., Delage J.A., 2023/11. Médecine Nucléaire, 47 (6) pp. 309-315.
 
Premières journées francophones des utilisateurs de système d’aide à la décision en pharmacie clinique : retour d’expériences et perspectives [First French-speaking days of users of decision support system in clinical pharmacy: Feedback and perspectives]
Robert L., Rousselière C., Beuscart J.B., Gautier S., Delporte L., Lafci G., Gerard E., Négrier L., Mary A., Johns E. et al., 2023/11. Annales pharmaceutiques francaises, 81 (6) pp. 1018-1030. Peer-reviewed.
 
Évaluation des risques liés aux médicaments pendant l’allaitement [Risk assessment of drugs during breastfeeding]
Cardoso E., Monfort A., Ferreira E., Fischer Fumeaux C.J., Henriot I., Winterfeld U., Gandia P., Guidi M., Panchaud A., 2023/10/18. Revue medicale suisse, 19 (846) pp. 1940-1947. Peer-reviewed.
 
Pénurie de médicaments pédiatriques - Retour vers le futur
Di Paolo E.R., von der Weid N., 2023/10/07. Competence 05 p. 11.
 
Modulateurs de la protéine CFTR pour traiter la mucoviscidose
Di Paolo E.R., Mitropoulou G., Csajka C, 2023/10/06. La Gazette médicale, 12 (06) pp. 20-22.
[68Ga]Ga-PentixaFor: Development of a fully automated in hospital production on the Trasis miniAllinOne synthesizer.
Costes J., Casasagrande K., Dubegny C., Castillo J., Kaufman J., Masset J., Vriamont C., Warnier C., Faivre-Chauvet A., Delage J.A., 2023/10. Journal of labelled compounds & radiopharmaceuticals, 66 (12) pp. 400-410. Peer-reviewed.
Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines.
Alcaraz-Serna A., Noto A., Ermellino L., Monzambani-Banderet V., Tommasini F., Stehlin F., Girard C., Perreau M., Muller Y.D., 2023/10. Allergology international, 72 (4) pp. 600-603. Peer-reviewed.
Risk of congenital malformation after first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort.
Favre G., Maisonneuve E., Pomar L., Daire C., Monod C., Martinez de Tejada B., Quibel T., Todesco-Bernasconi M., Sentilhes L., Blume C. et al., 2023/10. Clinical microbiology and infection, 29 (10) pp. 1306-1312. Peer-reviewed.
 
Automation of the medication process in Swiss hospitals: results of a survey.
Hufschmid Thurnherr E., Dahmke H., Voirol P., Waldispühl Suter B., Lutters M., Vonbach P., 2023/08/27. European journal of hospital pharmacy. Peer-reviewed.
 
Evolution of National Guidelines on Medicines Used to Treat COVID-19 in Pregnancy in 2020-2022: A Scoping Review.
Maisonneuve E., de Bruin O., Favre G., Goncé A., Donati S., Engjom H., Hurley E., Al-Fadel N., Siiskonen S., Bloemenkamp K. et al., 2023/07/06. Journal of clinical medicine, 12 (13). Peer-reviewed.
 
Modulatoren des CFTR-Proteins zur Behandlung der Mukoviszidose
Di Paolo E.R., Mitropoulou G., Csajka C., 2023/07/01. Der informierte @rtz, 13 (07) pp. 29-31.
 
Safety of monoclonal antibodies targeting PCSK9 in pregnancy: Analysis of the WHO's global pharmacovigilance database
Noseda Roberta, Bedussi Francesca, Panchaud Alice, Ceschi Alessandro, 2023/07. Neurotoxicology and Teratology, 98 p. 107242.
From bench to bedside: 64Cu/177Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applications.
Gnesin S., Chouin N., Cherel M., Dunn S.M., Schaefer N., Faivre-Chauvet A., Prior J.O., Delage J.A., 2023/06/14. EJNMMI research, 13 (1) p. 59. Peer-reviewed.
Dry alginate beads for fecal microbiota transplantation: From model strains to fecal samples.
Rakotonirina A., Galperine T., Audry M., Kroemer M., Baliff A., Carrez L., Sadeghipour F., Schrenzel J., Guery B., Allémann E., 2023/05/25. International journal of pharmaceutics, 639 p. 122961. Peer-reviewed.
 
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Favre G., Gerbier E., Maisonneuve E., Pomar L., Winterfeld U., Lepigeon K., Bloemenkamp KWM, de Bruin O., Eimir H., Nordeng H. et al., 2023/05. British journal of clinical pharmacology, 89 (5) pp. 1560-1574. Peer-reviewed.
 
Determinants of Vaccination and Willingness to Vaccinate against COVID-19 among Pregnant and Postpartum Women during the Third Wave of the Pandemic: A European Multinational Cross-Sectional Survey.
Maisonneuve E., Gerbier E., Tauqeer F., Pomar L., Favre G., Winterfeld U., Passier A., Oliver A., Baud D., Nordeng H. et al., 2023/04/29. Viruses, 15 (5) p. 1090. Peer-reviewed.
Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines.
Stehlin F., Tommasini F., Monzambani-Banderet V., Girard C., Yerly D., Ribi C., Muller Y.D., 2023/04. Allergology international, 72 (2) pp. 332-334. Peer-reviewed.
 
Digitalisation of the drug prescribing process in Swiss hospitals - results of a survey.
Vonbach P., Lutters M., Waldispühl Suter B., Voirol P., Higi L., Hufschmid Thurnherr E., 2023/03. European journal of hospital pharmacy, 30 (e1) pp. e101-e105. Peer-reviewed.
Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry.
Favre G., Maisonneuve E., Pomar L., Daire C., Poncelet C., Quibel T., Monod C., Martinez de Tejada B., Schäffer L., Papadia A. et al., 2023/03. The Lancet regional health. Europe, 26 p. 100569. Peer-reviewed.
 
Shall we rethink the timing of epidural anesthesia in anticoagulated obstetrical patients?
Legardeur H., Cuenoud A., Panchaud A., Grandoni F., Mesquita Sauvage A.B., Alberio L., Baud D., Gavillet M., 2023/03. American journal of obstetrics and gynecology, 228 (3) pp. 257-260. Peer-reviewed.
 
Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis.
Smith E.R., Oakley E., Grandner G.W., Rukundo G., Farooq F., Ferguson K., Baumann S., Adams Waldorf K.M., Afshar Y., Ahlberg M. et al., 2023/02. American journal of obstetrics and gynecology, 228 (2) pp. 161-177. Peer-reviewed.
Mental health of pregnant and postpartum women during the third wave of the COVID-19 pandemic: a European cross-sectional study.
Tauqeer F., Ceulemans M., Gerbier E., Passier A., Oliver A., Foulon V., Panchaud A., Lupattelli A., Nordeng H., 2023/01/11. BMJ open, 13 (1) pp. e063391. Peer-reviewed.
Antidiabetic Medication Utilisation before and during Pregnancy in Switzerland between 2012 and 2019: An Administrative Claim Database from the MAMA Cohort.
Gerbier E., Favre G., Maisonneuve E., Ceulemans M., Winterfeld U., Dao K., Schmid CPR, Jenkinson S.P., Niznik B., Baud D. et al., 2023. Journal of diabetes research, 2023 p. 4105993. Peer-reviewed.
Estimating glomerular filtration rate from serum creatinine concentration in children with augmented renal clearance: all formulas are equivocal, but some are more equivocal than others.
André P., Chtioui H., Dao K., Rothuizen L.E., Di Paolo E.R., Diezi M., Crisinel P.A., Cachat F., Chehade H., Buclin T., 2023/01. Kidney international, 103 (1) pp. 225-226. Peer-reviewed.
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project.
Monfort A., Cardoso E., Eap C.B., Fischer Fumeaux C.J., Graz M.B., Morisod Harari M., Weisskopf E., Gandia P., Allegaert K., Nordeng H. et al., 2023. Frontiers in psychiatry, 14 p. 1167870. Peer-reviewed.
Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis.
Abolhassani N., Winterfeld U., Kaplan Y.C., Jaques C., Minder Wyssmann B., Del Giovane C., Panchaud A., 2023/01. BMJ open diabetes research & care, 11 (1) pp. e002919. Peer-reviewed.
 
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project.
Cardoso E., Monfort A., Ferreira E., Nordeng H., Winterfeld U., Allegaert K., Gandia P., Guidi M., Panchaud A., 2023. Therapie, 78 (2) pp. 149-156. Peer-reviewed.
 
Pharmacie clinique au sein de quatre CHU de la francophonie, intégration et encadrement des pharmaciens cliniciens : une étude exploratoire [Clinical pharmacy in four French-speaking university hospitals, integration and supervision of clinical pharmacists: An exploratory study]
Décaudin B., Voirol P., Perrottet N., Spinewine A., Bussières J.F., 2023/01. Annales pharmaceutiques francaises, 81 (1) pp. 138-151. Peer-reviewed.
Reproductive Safety of Trazodone After Maternal Exposure in Early Pregnancy: A Comparative ENTIS Cohort Study.
Dao K., Shechtman S., Diav-Citrin O., George N., Richardson J.L., Rollason V., Pistelli A., Eleftheriou G., Berlin M., Ekobena P. et al., 2023. Journal of clinical psychopharmacology, 43 (1) pp. 12-19. Peer-reviewed.
 
Safety of medicines during breastfeeding - from case report to modeling: a contribution from the ConcePTION project.
Cardoso E., Guidi M., Nauwelaerts N., Nordeng H., Teil M., Allegaert K., Smits A., Gandia P., Edginton A., Ito S. et al., 2023. Expert opinion on drug metabolism & toxicology, 19 (5) pp. 269-283. Peer-reviewed.
 
The risk of questioning the safety of drugs considered safe in pregnancy at the era of big data: the everlasting case of doxylamine.
Panchaud A., Cleary B., Weber-Schoendorfer C., Shechtman S., Cassina M., Diav-Citrin O., Damkier P., 2022/12. Journal of clinical epidemiology, 152 pp. 125-126. Peer-reviewed.
 
Computer customization errors compromised the optimization of trace element repletion dose after major burns.
Dusapin C.J., Pantet O., Voirol P., Charrière M., Thomann P., Berger M.M., 2022/10. Clinical nutrition, 41 (10) pp. 2207-2210. Peer-reviewed.
Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection.
Pais J.P., Policarpo M., Pires D., Francisco A.P., Madureira A.M., Testa B., Anes E., Constantino L., 2022/09/30. Pharmaceuticals, 15 (10) p. 1213. Peer-reviewed.
Benzoic Acid Derivatives as Prodrugs for the Treatment of Tuberculosis.
Pais J.P., Magalhães M., Antoniuk O., Barbosa I., Freire R., Pires D., Valente E., Testa B., Anes E., Constantino L., 2022/09/07. Pharmaceuticals, 15 (9) p. 1118. Peer-reviewed.
Exploring the Reasons Behind the Substantial Discontinuation Rate Among Patients Taking CT-P13 in a Large Tertiary Hospital in Western Switzerland: A Retrospective Cohort Study Using Routinely Collected Medical Data.
Krstic M., Devaud J.C., Marti J., Sadeghipour F., 2022/09. Drugs - real world outcomes, 9 (3) pp. 425-436. Peer-reviewed.
Comment to "Pregnancy and COVID-19, focus on vaccine and pharmacological treatment".
Ceulemans M., Sillis L., Foulon V., Panchaud A., Winterfeld U., Pomar L., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2022/08. Journal of reproductive immunology, 152 p. 103639. Peer-reviewed.
Mutation to ispA Produces Stable Small-Colony Variants of Pseudomonas aeruginosa That Have Enhanced Aminoglycoside Resistance.
Pitton M., Oberhaensli S., Appiah F., Pagani J.L., Fournier A., Jakob S.M., Que Y.A., Cameron D.R., 2022/07/19. Antimicrobial agents and chemotherapy, 66 (7) pp. e0062122. Peer-reviewed.
COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study.
Favre G., Maisonneuve E., Pomar L., Winterfeld U., Daire C., Martinez de Tejada B., Delecraz D., Campelo S., Moser M., Todesco-Bernasconi M. et al., 2022/07. The Lancet regional health. Europe, 18 p. 100410. Peer-reviewed.
Recording of Chronic Diseases and Adverse Obstetric Outcomes during Hospitalizations for a Delivery in the National Swiss Hospital Medical Statistics Dataset between 2012 and 2018: An Observational Cross-Sectional Study.
Marxer C.A., Rauch M., Lang C., Panchaud A., Meier C.R., Spoendlin J., 2022/06/28. International journal of environmental research and public health, 19 (13). Peer-reviewed.
Queries on medication use during pregnancy: characterisation of the Swiss Teratogen Information Service database.
Baumgartner R., Winterfeld U., Panchaud A., Simões-Wüst A.P., 2022/05/23. Swiss medical weekly, 152 pp. w30187. Peer-reviewed.
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study.
Gerbier E., Favre G., Tauqeer F., Winterfeld U., Stojanov M., Oliver A., Passier A., Nordeng H., Pomar L., Baud D. et al., 2022/04/27. International journal of environmental research and public health, 19 (9) p. 5335. Peer-reviewed.
 
Drug dosages
Carai S., Jullien S., Maclennan C., Mutevelli J., Weber M., 2022/03/21. dans Pocket book of primary health care for children and adolescents, WHO Regional Office for Europe.
 
Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancy.
Damkier P., Cleary B., Weber-Schoendorfer C., Shechtman S., Cassina M., Panchaud A., Diav-Cirtin O., 2022/03. Nature reviews. Endocrinology, 18 (3) p. 191. Peer-reviewed.
Off-label use of psychotropic drugs in a Swiss paediatric service: similar results from two different cohort studies.
Feka A., Di Paolo E.R., Pauchard J.Y., Mariguesa A., Gehri M., Sadeghipour F., 2022/01/31. Swiss Medical Weekly, 152 pp. w30124. Peer-reviewed.
Use of Prescribed Drugs to Treat Chronic Diseases during Pregnancy in Outpatient Care in Switzerland between 2014 and 2018: Descriptive Analysis of Swiss Health Care Claims Data.
Gerbier E., Graber S.M., Rauch M., Marxer C.A., Meier C.R., Baud D., Winterfeld U., Blozik E., Surbek D., Spoendlin J. et al., 2022/01/27. International journal of environmental research and public health, 19 (3) p. 1456. Peer-reviewed.
Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries.
Ceulemans M., Foulon V., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2022/01/26. International journal of environmental research and public health, 19 (3) p. 1389. Peer-reviewed.
Antihistamine use during breastfeeding with focus on breast milk transfer and safety in humans: A systematic literature review.
Ngo E., Spigset O., Lupattelli A., Panchaud A., Annaert P., Allegaert K., Nordeng H., 2022/01. Basic & clinical pharmacology & toxicology, 130 (1) pp. 171-181. Peer-reviewed.
Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature.
Diciolla A., Gianoni M., Fleury M., Szturz P., Demartines N., Peters S., Duran R., Desseauve D., Panchaud M.A., Fasquelle F. et al., 2022. Frontiers in oncology, 12 p. 1006387. Peer-reviewed.
Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.
Stehlin F., Mahdi-Aljedani R., Canton L., Monzambani-Banderet V., Miauton A., Girard C., Kammermann K., Meylan S., Ribi C., Harr T. et al., 2022. Frontiers in allergy, 3 p. 818049. Peer-reviewed.
 
Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.
Papadimitriou-Olivgeris M., Cipriano A., Guggisberg N., Kroemer M., Tschopp J., Manuel O., Golshayan D., 2022. Transplant international, 35 p. 10721. Peer-reviewed.
Protocol for a sequential, prospective meta-analysis to describe coronavirus disease 2019 (COVID-19) in the pregnancy and postpartum periods.
Smith E.R., Oakley E., He S., Zavala R., Ferguson K., Miller L., Grandner G.W., Abejirinde I.O., Afshar Y., Ahmadzia H. et al., 2022. PloS one, 17 (6) pp. e0270150. Peer-reviewed.
Successful pregnancy in a cystic fibrosis patient with a severe impairment of lung function receiving Elexacaftor-Tezacaftor-Ivacaftor.
Balmpouzis Z., Faure van Rossum A., Baud D., Panchaud A., Mitropoulou G., Mazza Stalder J., Koutsokera A., 2022. Respiratory medicine case reports, 40 p. 101776. Peer-reviewed.
 
A review of the evidence on the risk of congenital malformations and neurodevelopmental disorders in association with antiseizure medications during pregnancy.
Marxer C.A., Rüegg S., Rauch M.S., Panchaud A., Meier C.R., Spoendlin J., 2021/12. Expert opinion on drug safety, 20 (12) pp. 1487-1499. Peer-reviewed.
Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety.
Delage J.A., Gnesin S., Prior J.O., Barbet J., Le Saëc P., Marionneau-Lambot S., Gouard S., Chérel M., Bourgeois M., Schaefer N. et al., 2021/11/25. Cancers, 13 (23) p. 5936. Peer-reviewed.
Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data.
Gerbier E., Graber S.M., Rauch M., Marxer C.A., Meier C.R., Baud D., Winterfeld U., Blozik E., Surbeki D., Spoendlin J. et al., 2021/11/22. Swiss medical weekly, 151 pp. w30048. Peer-reviewed.
 
Smarter medicine: «Liste Top-5» pour la pédiatrie
Wyder C., Gut D., Ramelli G.P., Ammann R., Berthet G., Di Paolo E.R., Gehri M., Huber B., Schnyder S., Sidler M., 2021/11/18. pharmaJournal 11 pp. 11-12.
Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2.
Farhat A., Panchaud A., Al-Hajje A., Lang P.O., Csajka C., 2021/11. European journal of clinical pharmacology, 77 (11) pp. 1747-1756. Peer-reviewed.
 
Pharmacists' considerations on non-medical switching at the hospital: a systematic review of the economic outcomes of cost-saving therapeutic drug classes.
Krstic M., Devaud J.A., Sadeghipour F., 2021/11. European journal of hospital pharmacy, 28 (Suppl 2) pp. e2-e7. Peer-reviewed.
 
Smarter medicine: «Liste Top-5» pour la pédiatrie
Wyder C., Gut D, Ramelli G.P., Ammann R., Berthet G., Di Paolo E.R., Gehri M., Huber B., Schnyder S., Sidler M., 2021/10/30. GSASA eNews 3 pp. 1-4.
 
Smarter medicine: «Liste Top-5» pour la pédiatrie
Wyder C., Gut D., Ramelli G.P., Ammann R., Berthet G., Di Paolo E.R., Gehri M., Huber B., Schnyder S, Sidler M, 2021/10/06. Primary and Hospital Care, 21 (10) pp. 313-315.
Corrigendum to: Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs.
Chemali M., Laurent A., Scaletta C., Waselle L., Simon J.P., Michetti M., Brunet J.F., Flahaut M., Hirt-Burri N., Raffoul W. et al., 2021/09/30..
Impact of the COVID-19 pandemic on Swiss pregnant and breastfeeding women - a cross-sectional study covering the first pandemic wave.
Lambelet V., Ceulemans M., Nordeng H., Favre G., Horsch A., Stojanov M., Winterfeld U., Baud D., Panchaud A., Pomar L., 2021/09/13. Swiss Medical Weekly, 151 pp. w30009. Peer-reviewed.
Impact of the COVID-19 pandemic on Swiss pregnant and breastfeeding women - a cross-sectional study covering the first pandemic wave.
Lambelet V., Ceulemans M., Nordeng H., Favre G., Horsch A., Stojanov M., Winterfeld U., Baud D., Panchaud A., Pomar L., 2021/09/13. Swiss medical weekly, 151 pp. w30009. Peer-reviewed.
Exposure to alirocumab during the first trimester of pregnancy: A case report.
Vuignier Y., Beaud F., Kosinski C., Panchaud A., Lebon S., Baud D., Kissling S., Collet T.H., 2021/09/01. Birth defects research, 113 (15) pp. 1156-1160. Peer-reviewed.
 
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysis.
Halfon M., Artru F., Fraga M., Comte D., Alberio L., Brunet J.F., Fakhouri F., Kissling S., 2021/09. Clinics and research in hepatology and gastroenterology, 45 (5) p. 101734. Peer-reviewed.
 
Effects of the Interactive Web-Based Video "Mon Coeur, Mon BASIC" on Drug Adherence of Patients With Myocardial Infarction: Randomized Controlled Trial.
Bruggmann C., Adjedj J., Sardy S., Muller O., Voirol P., Sadeghipour F., 2021/08/30. Journal of medical Internet research, 23 (8) pp. e21938. Peer-reviewed.
 
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199".
Stuckelberger S., Favre G., Ceulemans M., Gerbier E., Lambelet V., Stojanov M., Winterfeld U., Baud D., Panchaud A., Pomar L., 2021/08/05. Viruses, 13 (8) p. 1546. Peer-reviewed.
 
Clinical and economic impacts of explicit tools detecting prescribing errors: A systematic review.
Farhat A., Al-Hajje A., Csajka C., Panchaud A., 2021/08. Journal of clinical pharmacy and therapeutics, 46 (4) pp. 877-886. Peer-reviewed.
 
Impact of β-hydroxy-β-methylbutyrate (HMB) on muscle loss and protein metabolism in critically ill patients: A RCT.
Viana M.V., Becce F., Pantet O., Schmidt S., Bagnoud G., Thaden J.J., Ten Have GAM, Engelen MPKJ, Voidey A., Deutz NEP et al., 2021/08. Clinical nutrition, 40 (8) pp. 4878-4887. Peer-reviewed.
Activation of benzoate model prodrugs by mycobacteria. Comparison with mammalian plasma and liver hydrolysis.
Valente E., Testa B., Constantino L., 2021/07/01. European journal of pharmaceutical sciences, 162 p. 105831. Peer-reviewed.
 
Management of Atrial Fibrillation Following Cardiac Surgery: Observational Study and Development of a Standardized Protocol.
Bruggmann C., Astaneh M., Lu H., Tozzi P., Ltaief Z., Voirol P., Sadeghipour F., 2021/07. The Annals of pharmacotherapy, 55 (7) pp. 830-838. Peer-reviewed.
Maternal outcomes and risk factors for COVID-19 severity among pregnant women.
Vouga M, Favre G, Martinez-Perez O, Pomar L, Acebal LF, Abascal-Saiz A, Hernandez MRV, Hcini N, Lambert V, Carles G et al., 2021/07. Scientific reports.
Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic-A multinational cross-sectional study.
Ceulemans M., Foulon V., Ngo E., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O'Shaughnessy F., Passier A. et al., 2021/07. Acta obstetricia et gynecologica Scandinavica, 100 (7) pp. 1219-1229. Peer-reviewed.
SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland.
Stuckelberger S., Favre G., Ceulemans M., Nordeng H., Gerbier E., Lambelet V., Stojanov M., Winterfeld U., Baud D., Panchaud A. et al., 2021/06/22. Viruses, 13 (7) p. 1199. Peer-reviewed.
Association between confirmed congenital Zika infection at birth and outcomes up to 3 years of life.
Hcini N., Kugbe Y., Rafalimanana ZHL, Lambert V., Mathieu M., Carles G., Baud D., Panchaud A., Pomar L., 2021/06/01. Nature communications, 12 (1) p. 3270. Peer-reviewed.
Transplantation de microbiote fécal : de l’évidence aux réalités du terrain [Fecal microbiota transplantation: from the evidence to the realty of the field]
Ballif A., Gerber S., Carrez L., Audry M., Sadeghipour F., Mitouassiwou A., Croxatto A., Opota O., Prod'hom G., Henchoz S. et al., 2021/04/14. Revue medicale suisse, 17 (734) pp. 726-731. Peer-reviewed.
 
A comprehensive review on non-clinical methods to study transfer of medication into breast milk - A contribution from the ConcePTION project.
Nauwelaerts N., Deferm N., Smits A., Bernardini C., Lammens B., Gandia P., Panchaud A., Nordeng H., Bacci M.L., Forni M. et al., 2021/04. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 136 p. 111038. Peer-reviewed.
Prevalence and risk factors of lactic acidosis in children with acute moderate and severe asthma, a prospective observational study.
Ruman-Colombier M., Rochat Guignard I., Di Paolo E.R., Gehri M., Pauchard J.Y., 2021/04. European journal of pediatrics, 180 (4) pp. 1125-1131. Peer-reviewed.
Vaccine Willingness and Impact of the COVID-19 Pandemic on Women's Perinatal Experiences and Practices-A Multinational, Cross-Sectional Study Covering the First Wave of the Pandemic.
Ceulemans M., Foulon V., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2021/03/24. International journal of environmental research and public health, 18 (7) p. 3367. Peer-reviewed.
 
Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study.
Pauliat E., Onken M., Weber-Schoendorfer C., Rousson V., Addor M.C., Baud D., Théaudin M., Diav-Citrin O., Cottin J., Agusti A. et al., 2021/03. Multiple sclerosis, 27 (3) pp. 475-478. Peer-reviewed.
Maternal Infection and Adverse Pregnancy Outcomes among Pregnant Travellers: Results of the International Zika Virus in Pregnancy Registry.
Vouga M., Pomar L., Soriano-Arandes A., Rodó C., Goncé A., Gratacos E., Merriam A., Eperon I., Martinez De Tejada B., Eggel B. et al., 2021/02/22. Viruses, 13 (2) p. 341. Peer-reviewed.
Valproate in pregnancy: authors' reply.
Spoendlin J., Blozik E., Graber S., Rauch M., Marxer C., Ruegg S., Meier C., Winterfeld U., Panchaud A., 2021/02/15. Swiss medical weekly, 151 pp. w20481. Peer-reviewed.
 
Inhalation technique practical skills and knowledge among physicians and nurses in two pediatric emergency settings.
Spaggiari S., Gehri M., Di Benedetto L., Hafen G.M., Pauchard J.Y., Gervaix A., Pannatier A., Sadeghipour F., Di Paolo E.R., 2021/02. The Journal of asthma, 58 (2) pp. 190-196. Peer-reviewed.
Impact of Pharmaceutical Interventions in Hospitalized Patients: A Comparative Study Between Clinical Pharmacists and an Explicit Criteria-Based Tool.
Farhat A., Abou-Karroum R., Panchaud A., Csajka C., Al-Hajje A., 2021. Current therapeutic research, clinical and experimental, 95 p. 100650. Peer-reviewed.
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
Perrottet N., Fernández-Ruiz M., Binet I., Dickenmann M., Dahdal S., Hadaya K., Müller T., Schaub S., Koller M., Rotman S. et al., 2021. PloS one, 16 (4) pp. e0250829. Peer-reviewed.
Parenteral Nutrition Process Management for Newborn and Preterm Infants - A Preliminary Risk Analysis.
Sommer I., Palmero D., Fischer Fumeaux C.J., Bonnabry P., Bouchoud L., Sadeghipour F., 2021. Therapeutics and clinical risk management, 17 pp. 497-506. Peer-reviewed.
 
Smarter medicine: Liste Top 5 pour la pédiatrie
Wyder C., Gut D., Ramelli G.P., Ammann R., Berthet G., Di Paolo E.R., Gehri M., Huber B., Schnyder S., Sidler M., 2021. Bulletin des Médecins Suisses, 102 (31-32) pp. 985-987.
Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data.
Spoendlin J., Blozik E., Graber S., Rauch M., Marxer C., Rüegg S., Meier C., Winterfeld U., Panchaud A., 2021/01/01. Swiss medical weekly, 151 pp. w20386. Peer-reviewed.
SARS-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care.
Lambelet V., Vouga M., Pomar L., Favre G., Gerbier E., Panchaud A., Baud D., 2020/12. Prenatal diagnosis, 40 (13) pp. 1641-1654. Peer-reviewed.
Le bon moment pour un médicament: comment faire passer la pilule ? [The best time for a medication: how to sweeten the pill ?]
Nachar C., Perrottet N., Garnier A., 2020/11/25. Revue medicale suisse, 16 (716) pp. 2254-2258. Peer-reviewed.
 
Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS) (Preprint)
Bandiera Carole, Dotta-Celio Jennifer, Locatelli Isabella, Nobre Dina, Wuerzner Grégoire, Pruijm Menno, Lamine Faiza, Burnier Michel, Zanchi Anne, Schneider Marie Paule, 2020/11/23..
 
Placental infection by Zika virus in French Guiana.
Pomar L., Lambert V., Madec Y., Vouga M., Pomar C., Matheus S., Fontanet A., Panchaud A., Carles G., Baud D., 2020/11. Ultrasound in obstetrics & gynecology, 56 (5) pp. 740-748. Peer-reviewed.
Vertical transmission and materno-fetal outcomes in 13 patients with coronavirus disease 2019.
Masmejan S., Pomar L., Favre G., Panchaud A., Giannoni E., Greub G., Baud D., 2020/11. Clinical microbiology and infection, 26 (11) pp. 1585-1587. Peer-reviewed.
Zika Virus.
Masmejan S., Musso D., Vouga M., Pomar L., Dashraath P., Stojanov M., Panchaud A., Baud D., 2020/10/28. Pathogens, 9 (11) pp. E898. Peer-reviewed.
 
Quality and safety of parenteral nutrition for newborn and preterm infants as an on-ward preparation.
Sommer I., Bouchoud L., Berger-Gryllaki M., Bonnabry P., Sadeghipour F., 2020/09. European journal of hospital pharmacy, 27 (5) pp. 292-296. Peer-reviewed.
Adequacy of stress ulcer prophylaxis prescription in the intensive care unit: an observational study.
Franchitti M., Piubellini J., Sadeghipour F., Eckert P., Voirol P., Schneider A.G., 2020/08/24. Swiss medical weekly, 150 pp. w20322. Peer-reviewed.
Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study.
Bruggmann C., Fournier S., Panchaud A., Muller O., Sadeghipour F., Voirol P., 2020/08/10. Swiss medical weekly, 150 pp. w20321. Peer-reviewed.
 
A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk.
Weisskopf E., Guidi M., Fischer C.J., Bickle Graz M., Beaufils E., Nguyen K.A., Morisod Harari M., Rouiller S., Rothenburger S., Gaucherand P. et al., 2020/08. British journal of clinical pharmacology, 86 (8) pp. 1642-1653. Peer-reviewed.
 
Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.
Martínez-Perez O., Vouga M., Cruz Melguizo S., Forcen Acebal L., Panchaud A., Muñoz-Chápuli M., Baud D., 2020/07/21. JAMA, 324 (3) pp. 296-299. Peer-reviewed.
Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
Schwotzer N., Paganetti G., Barchi M., Perrottet N., Aubert V., Sadallah S., Rotman S., Venetz J.P., Matter M., Golshayan D. et al., 2020/07. Xenotransplantation, 27 (4) pp. e12630. Peer-reviewed.
 
Stability of N-Acetylcysteine (NAC) in Standardized Pediatric Parenteral Nutrition and Evaluation of N,N-Diacetylcystine (DAC) Formation.
Sommer I., Schwebel H., Adamo V., Bonnabry P., Bouchoud L., Sadeghipour F., 2020/06/21. Nutrients, 12 (6) p. 1849. Peer-reviewed.
Diabète post-transplantation rénale: le point de vue du diabétologue [Post-transplantation diabetes in kidney transplant: from the diabetologist point of view]
Pauchet A., Schwotzer N., Lamine F., Perrottet N., Zanchi A., Golshayan D., Wojtusciszyn A., 2020/06/10. Revue medicale suisse, 16 (697) pp. 1200-1205. Peer-reviewed.
 
Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
Gavillet M., Rolnik D.L., Hoffman M.K., Panchaud A., Baud D., 2020/06. Ultrasound in obstetrics & gynecology, 55 (6) pp. 843-844. Peer-reviewed.
An international registry for emergent pathogens and pregnancy.
Panchaud A., Favre G., Pomar L., Vouga M., Aebi-Popp K., Baud D., COVI-Preg group, 2020/05/09. Lancet, 395 (10235) pp. 1483-1484. Peer-reviewed.
Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study.
Bruggmann C., Iglesias J.F., Gex-Fabry M., Fesselet R., Vogt P., Sadeghipour F., Voirol P., 2020/02. American journal of cardiovascular drugs, 20 (1) pp. 105-115. Peer-reviewed.
Cortical Projection From the Premotor or Primary Motor Cortex to the Subthalamic Nucleus in Intact and Parkinsonian Adult Macaque Monkeys: A Pilot Tracing Study.
Borgognon S., Cottet J., Badoud S., Bloch J., Brunet J.F., Rouiller E.M., 2020. Frontiers in neural circuits, 14 p. 528993. Peer-reviewed.
Euthanasia and assisted suicide in patients with personality disorders: a review of current practice and challenges.
Mehlum L., Schmahl C., Berens A., Doering S., Hutsebaut J., Kaera A., Kramer U., Moran P.A., Renneberg B., Ribaudi J.S. et al., 2020. Borderline personality disorder and emotion dysregulation, 7 p. 15. Peer-reviewed.
Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis.
Perraudin C., Bourdin A., Vicino A., Kuntzer T., Bugnon O., Berger J., 2020. PloS one, 15 (11) pp. e0242630. Peer-reviewed.
 
A critical analysis of the neurodevelopmental and neurosensory outcomes after 2 years for children with in utero Zika virus exposure.
Vouga M., Pomar L., Panchaud A., Musso D., Baud D., 2019/11. Nature medicine, 25 (11) pp. 1641-1642. Peer-reviewed.
 
Gestion du traitement de l’asthme chez une femme enceinte
Levray Andréa, Berger Jérôme, Guignard Bertrand, Beney Johnny, Csajka Chantal, Panchaud Alice, 2019/10. pharmaJournal.
 
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence - an update.
Fischer Fumeaux C.J., Morisod Harari M., Weisskopf E., Eap C.B., Epiney M., Vial Y., Csajka C., Bickle Graz M., Panchaud A., 2019/10. Expert opinion on drug safety, 18 (10) pp. 949-963. Peer-reviewed.
 
Therapiemanagement von Asthma bei einer schwangeren Frau
Levray Andréa, Berger Jérôme, Guignard Bertrand, Beney Johnny, Csajka Chantal, Panchaud Alice, 2019/10. pharmaJournal.
 
Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.
MacDonald S.C., Cohen J.M., Panchaud A., McElrath T.F., Huybrechts K.F., Hernández-Díaz S., 2019/09. Pharmacoepidemiology and drug safety, 28 (9) pp. 1211-1221. Peer-reviewed.
 
FAME 3: Predicting the Sites of Metabolism in Synthetic Compounds and Natural Products for Phase 1 and Phase 2 Metabolic Enzymes.
Šícho M., Stork C., Mazzolari A., de Bruyn Kops C., Pedretti A., Testa B., Vistoli G., Svozil D., Kirchmair J., 2019/08/26. Journal of chemical information and modeling, 59 (8) pp. 3400-3412. Peer-reviewed.
Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study.
Michiels Y., Bugnon O., Chicoye A., Dejager S., Moisan C., Allaert F.A., Hunault C., Romengas L., Méchin H., Vergès B., 2019/06. Advances in therapy, 36 (6) pp. 1291-1303. Peer-reviewed.
 
Safety of medication use during pregnancy and breastfeeding
Panchaud A., Di Paolo E.R., 2019/05/20. pp. 1-16 dans Swiss recommendations for adult cystic fibrosis care chap. 13, Revue Médicale Suisse, Koutsokera A, Sauty A, et al..
 
Zika virus during pregnancy: From maternal exposure to congenital Zika virus syndrome.
Pomar L., Musso D., Malinger G., Vouga M., Panchaud A., Baud D., 2019/05. Prenatal diagnosis, 39 (6) pp. 420-430. Peer-reviewed.
 
Detection of a new melanoma in a patient treated with fingolimod.
Michiels Y., Bugnon O., Michiels J.F., Mazellier S., 2019/04/29. BMJ case reports, 12 (4). Peer-reviewed.
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Guidi M., Mercier T., Aouri M., Decosterd L.A., Csajka C., Ogutu B., Carn G., Kiechel J.R., 2019/04/18. Malaria journal, 18 (1) p. 139. Peer-reviewed.
 
Prediction of UGT-mediated Metabolism Using the Manually Curated MetaQSAR Database.
Mazzolari A., Afzal A.M., Pedretti A., Testa B., Vistoli G., Bender A., 2019/04/11. ACS medicinal chemistry letters, 10 (4) pp. 633-638. Peer-reviewed.
 
Genetic and clinic predictors of new onset diabetes mellitus after transplantation.
Saigi-Morgui N., Quteineh L., Bochud P.Y., Crettol S., Kutalik Z., Mueller N.J., Binet I., Van Delden C., Steiger J., Mohacsi P. et al., 2019/02. The pharmacogenomics journal, 19 (1) pp. 53-64. Peer-reviewed.
 
Trace element repletion following severe burn injury: A dose-finding cohort study.
Pantet O., Stoecklin P., Charrière M., Voirol P., Vernay A., Berger M.M., 2019/02. Clinical nutrition, 38 (1) pp. 246-251. Peer-reviewed.
 
Incident reports versus direct observation to identify medication errors and risk factors in hospitalised newborns.
Palmero D., Di Paolo E.R., Stadelmann C., Pannatier A., Sadeghipour F., Tolsa J.F., 2019. European Journal of Pediatrics, 178 (2) pp. 259-266. Peer-reviewed.
Multidisciplinary Collaboration between a Community Pharmacy and a Travel Clinic in a Swiss University Primary Care and Public Health Centre.
Berger J., Barbalat M.J., Pavón Clément V., Genton B., Bugnon O., 2018/12/05. Pharmacy, 6 (4) p. 126. Peer-reviewed.
Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results.
Lelubre M., Clerc O., Grosjean M., Amighi K., De Vriese C., Bugnon O., Schneider M.P., 2018/11/20. BMC health services research, 18 (1) p. 874. Peer-reviewed.
Prediction of the Formation of Reactive Metabolites by A Novel Classifier Approach Based on Enrichment Factor Optimization (EFO) as Implemented in the VEGA Program.
Mazzolari A., Vistoli G., Testa B., Pedretti A., 2018/11/13. Molecules, 23 (11) pp. E2955. Peer-reviewed.
 
Quelle alternative aux benzodiazépines, Z-pills et autres hypnotiques pour les personnes âgées ?: Mélatonine, valériane ou clométhiazole [Which alternative to benzodiazepines, Z-pills and other hypnotics for aged people ? Melatonin, valerian, or clomethiazole]
Dumur J., Csajka C., Pavec O., Messaoudi S., Cretignier T., Gaspar F., Lang P.O., 2018/11/07. Revue medicale suisse, 14 (626) pp. 2018-2023. Peer-reviewed.
 
Maternal-fetal transmission and adverse perinatal outcomes in pregnant women infected with Zika virus: prospective cohort study in French Guiana.
Pomar L., Vouga M., Lambert V., Pomar C., Hcini N., Jolivet A., Benoist G., Rousset D., Matheus S., Malinger G. et al., 2018/10/31. BMJ, 363 pp. k4431. Peer-reviewed.
 
Reply to Sorooshian and Snow, "Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?"
Fournier A., Eggimann P., Pantet O., Pagani J.L., Dupuis-Lozeron E., Pannatier A., Sadeghipour F., Voirol P., Que Y.A., 2018/10. Antimicrobial agents and chemotherapy, 62 (10). Peer-reviewed.
Implementation of an interprofessional medication adherence program for HIV patients: description of the process using the framework for the implementation of services in pharmacy.
Lelubre M., Clerc O., Grosjean M., Amighi K., De Vriese C., Bugnon O., Schneider M.P., 2018/09/10. BMC health services research, 18 (1) p. 698. Peer-reviewed.
 
Content analysis of antiretroviral adherence enhancing interview reports.
Kamal S., Nulty P., Bugnon O., Cavassini M., Schneider M.P., 2018/09. Patient education and counseling, 101 (9) pp. 1676-1682. Peer-reviewed.
 
Evaluating intimal hyperplasia under clinical conditions.
Mylonaki I., Allain E., Strano F., Allémann E., Corpataux J.M., Meda P., Jordan O., Delie F., Rougemont A.L., Haefliger J.A. et al., 2018/09/01. Interactive cardiovascular and thoracic surgery, 27 (3) pp. 427-436. Peer-reviewed.
 
Population Pharmacokinetic Study of Amoxicillin-Treated Burn Patients Hospitalized at a Swiss Tertiary-Care Center.
Fournier A., Goutelle S., Que Y.A., Eggimann P., Pantet O., Sadeghipour F., Voirol P., Csajka C., 2018/09. Antimicrobial agents and chemotherapy, 62 (9) pp. e00505-18. Peer-reviewed.
Changes of motor corticobulbar projections following different lesion types affecting the central nervous system in adult macaque monkeys.
Fregosi M., Contestabile A., Badoud S., Borgognon S., Cottet J., Brunet J.F., Bloch J., Schwab M.E., Rouiller E.M., 2018/08. The European journal of neuroscience, 48 (4) pp. 2050-2070. Peer-reviewed.
Effectiveness of a transition plan at discharge of patients hospitalized with heart failure: a before-and-after study.
Garnier A., Rouiller N., Gachoud D., Nachar C., Voirol P., Griesser A.C., Uhlmann M., Waeber G., Lamy O., 2018/08. ESC heart failure, 5 (4) pp. 657-667. Peer-reviewed.
 
Description and analysis of hospital pharmacies in Madagascar
Ratsimbazafimahefa H.R., Sadeghipour F., Trouiller P., Pannatier A., Allenet B., 2018/05. Annales Pharmaceutiques Françaises, 76 (3) pp. 218-227.
 
Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care Unit.
Fournier A., Eggimann P., Pantet O., Pagani J.L., Dupuis-Lozeron E., Pannatier A., Sadeghipour F., Voirol P., Que Y.A., 2018/03. Antimicrobial agents and chemotherapy, 62 (3) pp. e01818-17 . Peer-reviewed.
 
Medication reconciliation in a Swiss hospital: methods, benefits and pitfalls.
Nachar C., Lamy O., Sadeghipour F., Garnier A., Voirol P., 2018/01/30. European journal of hospital pharmacy, 26 (3) pp. 129-134. Peer-reviewed.
 
Arrêt cardiaque suite à l’administration accidentelle d’amphotéricine B sous forme désoxycholate
Cuda Loredana, Mury Caroline, Pagani Jean-Luc, Revelly Jean-Pierre, Livio Françoise, Aubert John-David, Schaller Marie-Denise, Voirol Pierre, Eggimann Philippe, Que Yok-Ai, 2018. Forum Medical Suisse, 18 (50) pp. 1067-1071. Peer-reviewed.
 
Médicaments, grossesse et allaitement
Panchaud Alice, Berger Jérôme, Bugnon Olivier, 2018. BabyGuide – Le Manuel officiel Suisse .
 
Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns
Palmero D., Chavan E., Berger-Gryllaki M., Tolsa J.F., Di Paolo E.R., Pannatier A., Henry H., Sadeghipour F., 2018. European Journal of Hospital Pharmacy, 25 pp. e109-114.
Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy.
Gayi E., Neff L.A., Massana Muñoz X., Ismail H.M., Sierra M., Mercier T., Décosterd L.A., Laporte J., Cowling B.S., Dorchies O.M. et al., 2018. Nature Communications, 9 (1) p. 4848. Peer-reviewed.
 
Pharmacist intervention acceptance for the reduction of potentially inappropriate drug prescribing in acute psychiatry.
Hannou S., Voirol P., Pannatier A., Weibel M.L., Sadeghipour F., von Gunten A., Mall J.F., De Giorgi Salamun I., 2017/12. International journal of clinical pharmacy, 39 (6) pp. 1228-1236. Peer-reviewed.
 
Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients' Adherence: Iphodia, a Cluster Randomized Study VS Usual Practice - 12 Month Final Results
Michiels Y, Bugnon O, Chicoye A, Verges B, Moisan C, Mechin H, Allaert F, 2017/10. pp. A483 dans Value in Health.
 
Suivi thérapeutique pharmacologique à la 4(e) journée de pharmacologie des anti-tumoraux [Therapeutic drug monitoring - 4th edition of the congress of pharmacology of anticancer drugs]
Allard M., Rousseau B., Cardoso E., Bellesoeur A., Blanchet B., 2017/09. Bulletin du cancer, 104 (9) pp. 800-806. Peer-reviewed.
 
Emergent chemodiversity: The case of stereoisomerism in acyclic alkanes.
Testa B., 2017/08. Chirality, 29 (8) pp. 415-421. Peer-reviewed.
 
Binding Space Concept: A New Approach To Enhance the Reliability of Docking Scores and Its Application to Predicting Butyrylcholinesterase Hydrolytic Activity.
Vistoli G., Mazzolari A., Testa B., Pedretti A., 2017/07/24. Journal of chemical information and modeling, 57 (7) pp. 1691-1702. Peer-reviewed.
High-resolution mass spectrometry as an alternative detection method to tandem mass spectrometry for the analysis of endogenous steroids in serum.
Ponzetto F., Boccard J., Baume N., Kuuranne T., Rudaz S., Saugy M., Nicoli R., 2017/05/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1052 pp. 34-42. Peer-reviewed.
 
An exploratory study on the use of traditional, complementary and alternative medicines (TCAM) by cancer patients
Fleury Mapi, peters solange, beck maja, sadeghipour farshid, 2017/04. dans Abstracts of the MASCC/ISOO 2017 Annual Meeting. Peer-reviewed.
 
Does the type of parenteral lipids matter? A clinical hint in critical illness.
Devaud J.C., Berger M.M., Pannatier A., Sadeghipour F., Voirol P., 2017/04. Clinical nutrition, 36 (2) pp. 491-496. Peer-reviewed.
 
Gastroprotective effects of hydroethanolic root extract of Arrabidaea brachypoda: Evidences of cytoprotection and isolation of unusual glycosylated polyphenols.
da Rocha C.Q., de-Faria F.M., Marcourt L., Ebrahimi S.N., Kitano B.T., Ghilardi A.F., Luiz Ferreira A., de Almeida A.C., Dunder R.J., Souza-Brito A.R. et al., 2017/04. Phytochemistry, 135 pp. 93-105. Peer-reviewed.
 
Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.
Aouri M., Barcelo C., Guidi M., Rotger M., Cavassini M., Hizrel C., Buclin T., Decosterd L.A., Csajka C., Swiss HIV Cohort Study, 2017/04. Antimicrobial agents and chemotherapy, 61 (1) p. 10. Peer-reviewed.
 
Staphylococcus aureus carriage at admission predicts early-onset pneumonia after burn trauma.
Fournier A., Voirol P., Krähenbühl M., Bonnemain C.L., Fournier C., Dupuis-Lozeron E., Pantet O., Pagani J.L., Revelly J.P., Sadeghipour F. et al., 2017/04. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 36 (3) pp. 523-528. Peer-reviewed.
 
Reliability of chemotherapy preparation processes: Evaluating independent double-checking and computer-assisted gravimetric control.
Carrez L., Bouchoud L., Fleury-Souverain S., Combescure C., Falaschi L., Sadeghipour F., Bonnabry P., 2017/03. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 23 (2) pp. 83-92. Peer-reviewed.
 
Massive copper and selenium losses cause life-threatening deficiencies during prolonged continuous renal replacement.
Ben-Hamouda N., Charrière M., Voirol P., Berger M.M., 2017/02. Nutrition (Burbank, Los Angeles County, Calif.), 34 pp. 71-75. Peer-reviewed.
 
Adverse drug reactions as a cause of admission to intensive care unit: a 4-months prospective cohort study
Berthaut V., Renard D., Schaller M.D., Manzon C., Voirol P., Buclin T., Livio F., 2017., 17th International Society of Pharmacovigilance (ISoP) Annual Meeting, Liverpool p. 944 dans Drug Safety.
 
Vade-mecum mucoviscidose en pédiatrie
Rochat I., Di Paolo E.R., Guérin S., 2017. 63, CHUV.
 
Marasmus
Rabinowitz S.S., Gehri M., Di Paolo E.R., Lawson Vaidy K., 2016/10. eMedecine pp. 1-30.
Biases affecting injected doses of an experimental drug during clinical trials.
Perrottet N., Brunner-Ferber F., Grouzmann E., Spertini F., Biollaz J., Buclin T., Widmer N., 2016/07/16. Trials, 17 (1) p. 321. Peer-reviewed.
 
Antibiotic consumption to detect epidemics of Pseudomonas aeruginosa in a burn centre: A paradigm shift in the epidemiological surveillance of Pseudomonas aeruginosa nosocomial infections.
Fournier A., Voirol P., Krähenbühl M., Bonnemain C.L., Fournier C., Pantet O., Pagani J.L., Revelly J.P., Dupuis-Lozeron E., Sadeghipour F. et al., 2016/05. Burns : journal of the International Society for Burn Injuries, 42 (3) pp. 564-570. Peer-reviewed.
 
Mechanisms and pharmaceutical consequences of processes of stereoisomerisation - A didactic excursion.
Testa B., Vistoli G., Pedretti A., 2016/04/10. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 88 pp. 101-123. Peer-reviewed.
 
A retrospective study of deep sternal wound infections: clinical and microbiological characteristics, treatment, and risk factors for complications.
Chan M., Yusuf E., Giulieri S., Perrottet N., Von Segesser L., Borens O., Trampuz A., 2016/03. Diagnostic microbiology and infectious disease, 84 (3) pp. 261-265. Peer-reviewed.
 
Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection.
Maiolo E.M., Oliva A., Furustrand Tafin U., Perrotet N., Borens O., Trampuz A., 2016/03. The Journal of infection, 72 (3) pp. 386-392. Peer-reviewed.
 
A bundle with a preformatted medical order sheet and an introductory course to reduce prescription errors in neonates.
Palmero D., Di Paolo E.R., Beauport L., Pannatier A., Tolsa J.F., 2016. European Journal of Pediatrics, 175 (1) pp. 113-119. Peer-reviewed.
 
Antifungal Quinoline Alkaloids from Waltheria indica.
Cretton S., Dorsaz S., Azzollini A., Favre-Godal Q., Marcourt L., Ebrahimi S.N., Voinesco F., Michellod E., Sanglard D., Gindro K. et al., 2016. Journal of Natural Products, 79 (2) pp. 300-307. Peer-reviewed.
Production of Fusaric Acid by Fusarium spp. in Pure Culture and in Solid Medium Co-Cultures.
Bohni N., Hofstetter V., Gindro K., Buyck B., Schumpp O., Bertrand S., Monod M., Wolfender J.L., 2016. Molecules, 21 (3) pp. 1-16. Peer-reviewed.
 
Safety of drugs during pregnancy and breastfeeding in cystic fibrosis patients.
Panchaud A., Di Paolo E.R., Koutsokera A., Winterfeld U., Weisskopf E., Baud D., Sauty A., Csajka C., 2016. Respiration; international review of thoracic diseases, 91 (4) pp. 333-348. Peer-reviewed.
Utility of an Algorithm to Increase the Accuracy of Medication History in an Obstetrical Setting.
Corbel A., Baud D., Chaouch A., Beney J., Csajka C., Panchaud A., 2016. Plos One, 11 (3) pp. e0151205. Peer-reviewed.
 
Demonstrating the clinical pharmacist's activity: validation of an intervention oriented classification system
Maes Karen A., Tremp Regina M., Hersberger Kurt E., Lampert Markus L., GSASA Working group on clinical pharmacy, 2015/12. International Journal of Clinical Pharmacy, 37 (6) pp. 1162-1171.
 
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU:
Voirol Pierre, Berger-Gryllaki Markoulina, Pannatier André, Eggimann Philippe, Sadeghipour Farshid, 2015/03. European Journal of Hospital Pharmacy, 22 (2) pp. 123-124.
 
Antibiotics' consumption to early detect epidemics of P. aeruginosa in a burn center: a paradigm shift in the epidemiological surveillance of nosocomial infections
Fournier A, Eggimann P, Pantet O, Krähenbühl M, Bonnemain C-L, Fournier C, Pagani J-L, Revelly J-P, Dupuis-Lozeron E, Sadeghipour F et al., 2015. pp. P232 dans 3rd International Conference on Prevention and Infection Control (ICPIC 2015), Antimicrobial Resistance and Infection Control. Peer-reviewed.
Caloric restriction induces energy-sparing alterations in skeletal muscle contraction, fiber composition and local thyroid hormone metabolism that persist during catch-up fat upon refeeding.
De Andrade P.B., Neff L.A., Strosova M.K., Arsenijevic D., Patthey-Vuadens O., Scapozza L., Montani J.P., Ruegg U.T., Dulloo A.G., Dorchies O.M., 2015. Frontiers In Physiology, 6 p. 254. Peer-reviewed.
 
Characterization of cation exchanger stationary phases applied for the separations of therapeutic monoclonal antibodies.
Fekete S., Beck A., Guillarme D., 2015. Journal of Pharmaceutical and Biomedical Analysis, 111 pp. 169-176. Peer-reviewed.
 
Effective Treatment of Invasive Aspergillus fumigatus Infection Using Combinations of Topical and Systemic Antifungals in a Severely Burned Patient.
Fournier A., Pantet O., Guerid S., Eggimann P., Pagani J.L., Revelly J.P., Hauser P.M., Marchetti O., Fontanella S., Letovanec I. et al., 2015. Journal of Burn Care and Research, 36 (2) pp. e85-e89. Peer-reviewed.
 
Efficacy and safety of high-dose daptomycin (>6mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram-positive bacteria.
Perrottet N., Steinrücken J., Chan M., Pannatier A., Borens O., Yusuf E., Trampuz A., 2015. International Journal of Antimicrobial Agents, 46 (4) pp. 480-482. Peer-reviewed.
Efficacy of Two Cleaning Solutions for the Decontamination of 10 Antineoplastic Agents in the Biosafety Cabinets of a Hospital Pharmacy
Anastasi M., Rudaz S., Queruau Lamerie T., Odou P., Bonnabry P., Fleury-Souverain S., 2015. Annals of Occupational Hygiene, 59 (7) pp. 895-908.
 
Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages
Pires , Valente , Simões , Carmo , Testa , Constantino , Anes , 2015. Antimicrobial Agents and Chemotherapy, 59 (12) pp. 7693-7699. Peer-reviewed.
 
Evaluation of a new wide-pore superficially porous material with carbon core and nanodiamond-polymer shell for the separation of proteins.
Fekete S., Jensen D.S., Zukowski J., Guillarme D., 2015. Journal of Chromatography. A, 1414 pp. 51-59. Peer-reviewed.
 
Evaluation of chemical contamination of surfaces during the preparation of chemotherapies in 24 hospital pharmacies
Fleury-Souverain Sandrine, Mattiuzzo Marc, Mehl Florence, Nussbaumer Susanne, Bouchoud Lucie, Falaschi Ludivine, Gex-Fabry Marianne, Rudaz Serge, Sadeghipour Farshid, Bonnabry Pascal, 2015. European Journal of Hospital Pharmacy, 22 (6) pp. 333-341.
 
Grossesse, naissance et les trois premières années de l’enfant
Panchaud Alice, Berger Jérôme, Bugnon Olivier, 2015. dans BabyGuide – Le Manuel officiel Suisse, BabyGuide.
 
How the flexibility of human histone deacetylases influences ligand binding: an overview.
Deschamps N., Simões-Pires C.A., Carrupt P.A., Nurisso A., 2015. Drug Discovery Today, 20 (6) pp. 736-742. Peer-reviewed.
 
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
Fournier A., Eggimann P., Pagani J.L., Revelly J.P., Decosterd L.A., Marchetti O., Pannatier A., Voirol P., Que Y.A., 2015. Burns, 41 (5) pp. 956-968. Peer-reviewed.
 
Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix A.L., Di Paolo E.R., Dolci U., Berger-Gryllaki M., Cotting J., Pannatier A., 2015. Respiratory Care, 60 (1) pp. 38-46.
 
Portrait d'Ermindo Di Paolo
Di Paolo E.R., Philbet T., 2015. PharmaJournal 3 pp. 32-33.
 
Predicting drug metabolism: experiment and/or computation?
Kirchmair J., Göller A.H., Lang D., Kunze J., Testa B., Wilson I.D., Glen R.C., Schneider G., 2015. Nature Reviews. Drug Discovery, 14 (6) pp. 387-404. Peer-reviewed.
 
Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide
Humbert-Delaloye Valia, Berger-Gryllaki Markoulina, Voirol Pierre, Testa Bernard, Pannatier André, 2015/01. European Journal of Hospital Pharmacy, 22 (1) pp. 56-58.
 
Sources d'exposition aux phtalates dans une unité de soins néonatals [Phthalate exposure in the neonatal intensive care unit].
Fischer Fumeaux C.J., Stadelmann Diaw C., Palmero D., M'Madi F., Tolsa J.F., 2015. Archives de Pédiatrie, 22 (2) pp. 203-210. Peer-reviewed.
Stop using the flotation technique and start weighing salbutamol pressurised metered-dose inhalers without dose counters.
Di Paolo E.R., Spaggiari S., Pannatier A., Sadeghipour F., Rochat I., Hafen G.M., 2015. Swiss Medical Weekly, 145 pp. w14162. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University